Advanced search
Publication Cover
International Journal of General Medicine Volume 16, 2023 - Issue
Submit an article Journal homepage
203
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

A Retrospective Study of Pneumococcal Pneumonia in Hospitalized Patients Aged ≥65 Years in Izumo, Japan: 2010 to 2014

Megumi Hamaguchi1 Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University, Izumo, Shimane, JapanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1995-9217View further author information
ORCID Icon,
Yukari Tsubata1 Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University, Izumo, Shimane, JapanORCID Iconhttps://orcid.org/0000-0002-4260-2849View further author information
ORCID Icon,
Ken Yoshihara1 Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University, Izumo, Shimane, JapanView further author information
,
Mika Nakao1 Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University, Izumo, Shimane, JapanView further author information
,
Yoshihiro Amano1 Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University, Izumo, Shimane, JapanView further author information
,
Kazuhisa Nakashima1 Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University, Izumo, Shimane, JapanView further author information
,
Takamasa Hotta2 Department of Respiratory Medicine, Shimane Prefectural Central Hospital, Izumo, Shimane, JapanORCID Iconhttps://orcid.org/0000-0002-7935-7285View further author information
ORCID Icon,
Tamio Okimoto1 Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University, Izumo, Shimane, JapanView further author information
,
Shunichi Hamaguchi3 Department of General Medicine, Shimane University, Izumo, Shimane, JapanView further author information
,
Akihisa Sutani4 Sutani Respiratory Clinic, Izumo, Shimane, JapanView further author information
&
Takeshi Isobe1 Division of Medical Oncology and Respiratory Medicine, Department of Internal Medicine, Shimane University, Izumo, Shimane, JapanView further author information
 show all
Pages 2125-2132 | Received 27 Feb 2023, Accepted 26 May 2023, Published online: 30 May 2023

References

  • Ishida T, Tachibana H, Ito A, et al. Clinical characteristics of nursing and healthcare-associated pneumonia: aJapanese variant of healthcare-associated pneumonia. Intern Med. 2012;51(18):2537–2544. doi:10.2169/internalmedicine.51.7987
  • Shindo Y, Ito R, Kobayashi D, et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2013;188:985–995. doi:10.1164/rccm.201301-0079OC
  • Tleyieh IM, Tlaygeh HM, Hejal R, et al. The impact of penicillin resistance on short-term mortality in hospitalized adults with pneumococcal pneumonia: a systematic review and meta-analysis. Clin Infect Dis. 2006;42:788–797. doi:10.1086/500140
  • Aspa J, Rajas O, Rodriguez de Castro F, et al. Impact of initial antibiotic choice on mortality from pneumococcal pneumonia. Eur Respir J. 2006;27:1010–1019. doi:10.1183/09031936.06.00126004
  • Fedson DS. Pneumococcal conjugate vaccination for older adults. Hum Vaccine Immunother. 2013;10:47–51. doi:10.4161/hv.26422
  • Moderley S, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013;1:CD000422.
  • Kawakami K, Ohkusa Y, Kuroki R, et al. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Vaccine. 2010;28(43):7063–7069. doi:10.1016/j.vaccine.2010.08.010
  • Morimoto K, Suzuki M, Ishifuji T, et al. The burden and etiology of community-onset pneumonia in the aging Japanese population: a multicenter prospective study. PLoS One. 2015;10:e0122247. doi:10.1371/journal.pone.0122247
  • Maruyama T, Taguchi O, Niederman MS, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind randomized and placebo controlled trial. BMJ. 2010;340:c1004. doi:10.1136/bmj.c1004
  • Suzuki M, Dhoubhadel BG, Ishifuji T, et al. Adult Pneumonia Study Group-Japan (APSG-J). Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. Lancet Infect Dis. 2017;17:313–321. doi:10.1016/S1473-3099(17)30049-X
  • Naito T, Matsuda N, Tanei M, et al. Relationship between public subsidies and vaccination rates with the 23-valent pneumococcal vaccine in elderly persons, including the influence of the free vaccination campaign after the Great East Japan Earthquake. J Infect Chemother. 2014;20(7):450–453. doi:10.1016/j.jiac.2014.03.004
  • Jung SM, Lee H, Nishiura H. The impact of pneumococcal vaccination on pneumonia mortality among the elderly in Japan: a difference-in-difference study. PeerJ. 2018;12;6:e6085. doi:10.7717/peerj.6085
  • Committee for the Japanese Respiratory Society guidelines for the management of respiratory infections. The JRS guidelines for the management of community-acquired pneumonia in adults. Tokyo. Japanese Respiratory Society; 2007. Japanese.
  • Committee for the Japanese Respiratory Society guidelines for the management of respiratory infections. The JRS guidelines for the management of hospital-acquired pneumonia in adults. Tokyo: Japanese Respiratory Society; 2008. Japanese.
  • Committee for the Japanese Respiratory Society guidelines for the management of nursing and healthcare-associated pneumonia (NHCAP). The JRS guidelines for the management of nursing and healthcare-associated pneumonia.Tokyo: Japanese Respiratory Society; 2011. Japanese.
  • Alfageme I, Vazquez R, Reyes N, et al. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax. 2006;61:189–195. doi:10.1136/thx.2005.043323
  • Ortqvist A, Hedlund J, Burman LA; Swedish Pneumococcal Vaccination Study Group, et al. Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Lancet. 351;1998:399–403. doi:10.1016/S0140-6736(97)07358-3
  • Greenberg RN, Gurtman A, Frenck RW, et al. Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60–64 years of age. Vaccine. 2014;32:2364–2374. doi:10.1016/j.vaccine.2014.02.002

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.